Di Nuzzo Private Wealth, Inc. Haemonetics Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $658 Million
- Q2 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 8 shares of HAE stock, worth $445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 9
11.11%
Holding current value
$445
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HAE
# of Institutions
354Shares Held
53MCall Options Held
653KPut Options Held
553K-
Black Rock Inc. New York, NY5.96MShares$332 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$284 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$242 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$146 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$122 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.85B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...